CYP2D6 genetic polymorphisms impact on tamsulosin efficacy and safety in patients with benign prostatic hyperplasia

Drug Metabolism and Personalized Therapy · Published 2025-02-13 · DOI 10.1515/dmpt-2024-0061

Authors being retrieved — see the publisher record. https://doi.org/10.1515/dmpt-2024-0061

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• The impact of antihistamine use on allergic reactions in pregnancy · Drug Metabolism and Personalized Therapy · 2026 · Same journal
• Helicobacter pylori eradication therapy for children · Drug Metabolism and Personalized Therapy · 2024 · Same journal
• Effect of a polyherbal Unani formulation on left ventricular diastolic dysfunction in hypertensive patients – a randomized single blind placebo controlled clinical trial · Drug Metabolism and Personalized Therapy · 2024 · Same journal
• Navigating the crossroads of cell death interplay and intersections among ferroptosis, apoptosis and autophagy · Drug Metabolism and Personalized Therapy · 2025 · Same journal
• Application of herbal liniment ( ′Ṭilā ) in the management of pain and disability of chronic migraine: a randomized controlled trial · Drug Metabolism and Personalized Therapy · 2026 · Same journal
• In vivo and in vitro evaluation of antibacterial and anti-inflammatory activities of extraction of crude saponin isolated from licorice roots against Streptococcus pneumoniae · Drug Metabolism and Personalized Therapy · 2025 · Same journal
• Allele frequencies of pharmacogenetic biomarkers and genomic ancestry in a sample of the Cuban population · Drug Metabolism and Personalized Therapy · 2026 · Same journal
• Exploring two medicinally important Selinum species: bridging traditional knowledge with modern pharmacological insights · Drug Metabolism and Personalized Therapy · 2025 · Same journal
• Unlocking the therapeutic potential and personalized therapy of testosterone: a comprehensive review · Drug Metabolism and Personalized Therapy · 2024 · Same journal
• Status of the implementation of pharmacogenetics in clinical practice in Spain: from regional to national initiatives · Drug Metabolism and Personalized Therapy · 2024 · Same journal